Notice: Prescription Drug List (PDL): Multiple Additions (2021-09-10)
The purpose of this Notice of Amendment is to notify about the additions of: Elexacaftor, Inclisiran, Ospemifene, Pralsetinib and Tafasitamab to the Prescription Drug List (PDL) for human and veterinary use, and Frunevetmab to the PDL for veterinary use.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Notice: Prescription Drug List (PDL): Multiple Additions (2021-09-10)HTMLEnglish publication HTML
-
Notice: Prescription Drug List (PDL): Multiple Additions (2021-09-10)HTMLFrench publication HTML
Similar records